title: Aciclovir treatment for human immunodeficiency virus-1: is the “juice worth the squeeze?”.
authors.forename: Myron S
authors.initials: MS
authors.lastname: Cohen
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Eron
mesh_terms: D000212:Acyclovir / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D060085:Coinfection / Q000188:drug therapy / Q000453:epidemiology; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control*; D006558:Herpes Genitalis / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology; D018258:Herpesvirus 2, Human / Q000187:drug effects*; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir